Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
13 auth.
J. Smolen,
J. Kay,
M. Doyle,
R. Landewé,
E. Matteson,
J. Wollenhaupt,
N. Gaylis,
F. Murphy,
J. Neal,
Yiying Zhou,
...
S. Visvanathan,
E. Hsia,
Mahboob Rahman
|
|
9 |
2009 |
Social Media Posts